These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 35937942)
1. CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma. Wang H; Wang X; Xu L; Lin Y; Zhang J Dis Markers; 2022; 2022():1560199. PubMed ID: 35937942 [TBL] [Abstract][Full Text] [Related]
2. CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis. Yu SK; Yu T; Wang YM; Sun A; Liu J; Lu KH J Transl Med; 2024 May; 22(1):460. PubMed ID: 38750462 [TBL] [Abstract][Full Text] [Related]
3. Nonnegative matrix factorization-based bioinformatics analysis reveals that TPX2 and SELENBP1 are two predictors of the inner sub-consensuses of lung adenocarcinoma. Wang H; Wang X; Xu L; Cao H; Zhang J Cancer Med; 2021 Dec; 10(24):9058-9077. PubMed ID: 34734491 [TBL] [Abstract][Full Text] [Related]
4. CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration. Wei Y; Vellanki RN; Coyaud É; Ignatchenko V; Li L; Krieger JR; Taylor P; Tong J; Pham NA; Liu G; Raught B; Wouters BG; Kislinger T; Tsao MS; Moran MF Mol Cancer Res; 2015 Jul; 13(7):1119-29. PubMed ID: 25784717 [TBL] [Abstract][Full Text] [Related]
5. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study. He T; Yu D; Wang Z; Guo C; Chang Y; Wang D Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891 [TBL] [Abstract][Full Text] [Related]
6. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients. Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925 [TBL] [Abstract][Full Text] [Related]
7. CCT5 interacts with cyclin D1 promoting lung adenocarcinoma cell migration and invasion. Meng Y; Yang L; Wei X; Luo H; Hu Y; Tao X; He J; Zheng X; Xu Q; Luo K; Yu G; Luo Q Biochem Biophys Res Commun; 2021 Aug; 567():222-229. PubMed ID: 34217974 [TBL] [Abstract][Full Text] [Related]
8. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients. Ma J; Yang L; Feng H; Zheng L; Meng H; Li X J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992 [TBL] [Abstract][Full Text] [Related]
9. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma. Liu X; Chen L; Zhang T Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532 [TBL] [Abstract][Full Text] [Related]
10. Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer. Sun H; Wang Y; Jing HY; Yang XY; Shi XX; Zhang JH; Yu YX; Gao L; Wang XY; Li WH; Yu L Front Genet; 2021; 12():629856. PubMed ID: 34017352 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma. Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091 [TBL] [Abstract][Full Text] [Related]
12. Tectoridin and PLK1 inhibitor synergistically promote the apoptosis of lung adenocarcinoma cells: Bioinformatic analysis of TCGA and TCMSP. Wang M; Zhao F; Li Z; Li X; Dong L Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2417-2426. PubMed ID: 37014402 [TBL] [Abstract][Full Text] [Related]
13. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis. Wang W; He J; Lu H; Kong Q; Lin S Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739 [TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer. Huang K; Zeng Y; Xie Y; Huang L; Wu Y Mol Med Rep; 2019 May; 19(5):4344-4352. PubMed ID: 30942452 [TBL] [Abstract][Full Text] [Related]
15. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma. Xu XL; Gong Y; Zhao DP Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913 [TBL] [Abstract][Full Text] [Related]
16. High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets. Wang H; Wang X; Xu L; Zhang J; Cao H Purinergic Signal; 2020 Sep; 16(3):347-366. PubMed ID: 32638267 [TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance. Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
19. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma. Zhang T; Shi W; Tian K; Kong Y World J Surg Oncol; 2020 Jul; 18(1):156. PubMed ID: 32631353 [TBL] [Abstract][Full Text] [Related]
20. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma. Chen D; Luo L; Liang C PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]